ROI Influencers: Health Care 2024
Lars Fruergaard Jørgensen; Doug Langa
CEO & president; EVP, North America operations and president
Novo Nordisk
As if the success of their wonder drugs for weight loss, Wegovy and Ozempic, wasn’t enough, the company announced that its study of Rybelsus, an oral form of semaglutide, slashed the risk of major cardiovascular events by 14% in type 2 diabetes patients who also face cardiovascular or kidney complications. The Danish company, which makes its North American headquarters in Plainsboro, is thought to be looking for more office and, potentially, manufacturing space in the state.